APA (7th ed.) Citation

Kang, J., Park, K. W., Han, J., Hwang, D., Yang, H., Park, S., . . . Jo, S. (2025). Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): An open-label, multicentre, randomised clinical trial. Lancet, 406(10516), 2244. https://doi.org/10.1016/S0140-6736(25)01571-5

Chicago Style (17th ed.) Citation

Kang, Jeehoon, et al. "Dual Antiplatelet Therapy After Percutaneous Coronary Intervention According to Bleeding Risk (HOST-BR): An Open-label, Multicentre, Randomised Clinical Trial." Lancet 406, no. 10516 (2025): 2244. https://doi.org/10.1016/S0140-6736(25)01571-5.

MLA (9th ed.) Citation

Kang, Jeehoon, et al. "Dual Antiplatelet Therapy After Percutaneous Coronary Intervention According to Bleeding Risk (HOST-BR): An Open-label, Multicentre, Randomised Clinical Trial." Lancet, vol. 406, no. 10516, 2025, p. 2244, https://doi.org/10.1016/S0140-6736(25)01571-5.